Van Morris, Section Chief of Colorectal Cancer and Associate Professor at MD Anderson Cancer Center, shared a post on X:
“Fantastic analysis of AtezoTRIBE and AVETRIC trials utilizing AI to predict benefit from IO in patients with MSS CRC- it’s wild that this biomarker work can be done from a single archival H&E slide.
This approach will improve feasibility to analyze biomarkers in large, multi-center trials moving forward. Industry should take note!!
Congrats to Chiara Cremolini and study team.”
You can also read:
ESMO 2025 Day 1 Highlights Not to Miss
ESMO 2025 Day 2 Highlights Not to Miss
ESMO 2025 Day 3 Highlights Not to Miss
ESMO 2025 Day 4 Highlights Not to Miss
